CIMB Securities initiates Sunway Healthcare with hold rating
Updated
Updated · The Wall Street Journal · May 7
CIMB Securities initiates Sunway Healthcare with hold rating
8 articles · Updated · The Wall Street Journal · May 7
It set a 1.88 ringgit target price as shares traded 1.6% higher at 1.89 ringgit, saying the stock’s 29% gain since its IPO already reflects much of its earnings potential.
Analyst Chun Sung Oong forecasts a 23.6% earnings CAGR for 2025-2028, supported by brownfield expansion projects, higher patient intensity and plans to add 477 beds by 2028.
That would lift total capacity to 2,422 beds, while integration with parent Sunway’s township, hospitality and education assets is expected to support patient traffic and medical tourism.
Is Sunway Healthcare's stock, at 100 times earnings, a bubble or a justified bet on Asia's healthcare boom?
With its top drug facing a patent cliff, can Sanofi's €25 billion M&A gamble successfully rebuild its pipeline?
As big pharma's revenues face a patent cliff, can AI-driven R&D truly replace the next wave of blockbuster drugs?